Yuanbao Inc. ADR logo

Yuanbao Inc. ADR (YB)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS)
$
11. 52
+0.44
+3.9711%
$
90.6M Market Cap
- P/E Ratio
- Div Yield
23,727 Volume
- Eps
$ 11.08
Previous Close
Add Transaction
Day Range
11.12 11.86
Year Range
11.01 24.4
Want to track YB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

YB closed yesterday higher at $11.52, an increase of 3.9711% from Thursday's close, completing a monthly decrease of -16.6425% or -$2.3. Over the past 12 months, YB stock lost -42.6295%.
YB pays dividends to its shareholders, with the most recent payment made on Jul 28, 2026. The next estimated payment will be in 2 months ago on Jul 28, 2026 for a total of $1.26.
The last earnings report, released on Jun 04, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

YB Chart

People also search for

Fulcrum Therapeutics Inc.
$ 3.65
-0.545%
EyePoint Pharmaceuticals Inc.
$ 2.99
-4.7771%
Rocket Pharmaceuticals Inc.
$ 2.18
-7.6271%
Larimar Therapeutics Inc.
$ 1.99
-0.2513%
KraneShares Global Healthcare & Environmental Index ETF
$ 32.47
-1.2169%
Yuanbao: Still Worth Hanging On To

Yuanbao: Still Worth Hanging On To

The release of the Q2 FY2026 report gave plenty of reason to stick with long YB, even though that has yet to truly pay off. Yuanbao has been slowly moving higher in the past few months, but a look at a chart suggests one has to remain on guard. Regulatory uncertainty is a headwind for YB, but YB also has a number of strengths, including a dividend payout that looks sustainable.

Seekingalpha | 1 month ago
Yuanbao: Bullish On Earnings Growth Acceleration And Dividend Commitment

Yuanbao: Bullish On Earnings Growth Acceleration And Dividend Commitment

I initiate Yuanbao Inc. with a Buy rating after evaluating its performance and outlook. YB's 33% bottom-line expansion for 2Q2026 was driven by supportive Chinese insurance policies, and AI-driven cost efficiencies. The commitment to progressive cash payouts sends a positive signal about management's confidence in future prospects.

Seekingalpha | 1 month ago
Yuanbao Q2 Earnings Call Highlights

Yuanbao Q2 Earnings Call Highlights

Yuanbao NASDAQ: YB reported second-quarter 2026 revenue of RMB 1.39 billion, up 30.1% from a year earlier, as growth in insurance distribution and system services supported higher profitability.

Marketbeat | 1 month ago

Yuanbao Inc. ADR Investors

Name Quantity Cost Value Profit ($) Gain (%)
NA
Nizar Araji National Bank Of Canada /FI/
3,000 $52,920 $33,240 -$19,680 -37.19%
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
104,705 $1.96M $1.16M -$801,371.9 -40.85%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
3 $46 $33.24 -$12.76 -27.74%
WL
Wealthcollab LLC WealthCollab, LLC
164 $3,323 $1,820.4 -$1,502.6 -45.22%

Yuanbao Inc. ADR (YB) FAQ

What is the stock price today?

The current price is $11.52.

On which exchange is it traded?

Yuanbao Inc. ADR is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is YB.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 90.6M.

Has Yuanbao Inc. ADR ever had a stock split?

No, there has never been a stock split.

Yuanbao Inc. ADR Profile

Pharmaceuticals Industry
Healthcare Sector
Rui Fang CEO
NASDAQ (NMS) Exchange
987910106 CUSIP
CN Country
613 Employees
2 Jul 2026 Last Dividend
- Last Split
- IPO Date

Overview

Yuanbao Inc. is a prominent player in the online insurance distribution sector within the People's Republic of China. Established in 2019, the company operates from its headquarters in Beijing and has expanded its operations through a network of subsidiaries. Yuanbao Inc. is dedicated to providing a wide range of insurance products, including medical, critical illness, and life insurance. Additionally, the company invests in system services that enhance the efficiency and effectiveness of its marketing and analytics efforts, contributing to a comprehensive service environment for its clients.

Products and Services

  • Medical Insurance:

    Yuanbao Inc. offers various medical insurance plans that cover a broad spectrum of healthcare needs. These products aim to provide financial support during medical emergencies or healthcare encounters, ensuring that policyholders can access necessary treatments without significant out-of-pocket expenses.

  • Critical Illness Insurance:

    This insurance product is designed to support individuals diagnosed with serious health conditions. Yuanbao Inc. provides critical illness plans that offer a lump-sum payment upon diagnosis, helping policyholders manage expensive medical treatments and maintain financial stability during recovery.

  • Life Insurance:

    The company's life insurance offerings are structured to provide financial protection to beneficiaries in case of the policyholder's untimely death. Yuanbao Inc. seeks to offer peace of mind through its life insurance products, ensuring that families and loved ones are financially secure.

  • Other Insurance Products:

    Yuanbao Inc. also caters to clients' diverse insurance needs with additional products that may include accident insurance, travel insurance, and property insurance. These options are tailored to meet various personal and business requirements, extending comprehensive coverage solutions to its clientele.

  • System Services:

    Beyond insurance products, Yuanbao Inc. provides system services that include precise marketing and analytics solutions. These services are geared toward enhancing the company's operational capabilities, enabling better targeting of potential clients and optimizing the overall distribution process. By leveraging advanced analytics, Yuanbao aims to improve customer engagement and increase service efficacy.

Contact Information

Address: Building 2
Phone: 86 10 6484 9901